Complete remission of psoriasis following bevacizumab therapy for colon cancer

---

Atıf İçin Kopyala

AKMAN A. N., YILMAZ E., Mutlu H., Ozdogan M.

CLINICAL AND EXPERIMENTAL DERMATOLOGY, cilt.34, sa.5, 2009 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 34 Sayı: 5
• Basım Tarihi: 2009
• Doi Numarası: 10.1111/j.1365-2230.2008.02991.x
• Dergi Adı: CLINICAL AND EXPERIMENTAL DERMATOLOGY
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Akdeniz Üniversitesi Adresli: Evet

Özet

Bevacizumab is a monoclonal antibody against vascular endothelial growth factor (VEGF), which is used to treat several cancers. Currently, experience with anti-VEGF treatment for psoriasis is limited, and no published reports on this use exist. We describe a patient with metastatic colon cancer and psoriasis who experienced complete remission of psoriasis during treatment with bevacizumab and combination chemotherapy without any other treatment for psoriasis. These data suggest that bevacizumab may be a promising therapeutic agent for the treatment of psoriasis.